Adial Pharmaceuticals, Inc.
USD2.67
+0.08 (+3.09%)
CEO
Cary John Claiborne
IPO Date
2018-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.63
Prev. Close
$2.59
Day Low
$2.52
Day High
$2.69
52W Low
$1.31
52W High
$19.00
Market Cap
$0.00B
Volume
0.03M
| 3,427 |
| $0.00 |
| 16 Jun 2026 | Davidson Matt | director, officer: Chief Development Officer | A-Award | Acquired | 232,417 | $0.00 |
| 16 Jun 2026 | Davidson Matt | director, officer: Chief Development Officer | A-Award | Acquired | 1,822.13 | $0.00 |
| 16 Jun 2026 | Davidson Matt | director, officer: Chief Development Officer | A-Award | Acquired | 101.298 | $0.00 |
| 16 Jun 2026 | Davidson Matt | director, officer: Chief Development Officer | A-Award | Acquired | 232,417 | $2.89 |
| 16 Jun 2026 | Davidson Matt | director, officer: Chief Development Officer | Disposed | 0 | $0.00 |
| 16 Jun 2026 | Young Wendy B. | director | P-Purchase | Acquired | 36,378 | $0.00 |
| 16 Jun 2026 | Young Wendy B. | director: | Disposed | 0 | $0.00 |
| 9 Apr 2026 | Goodman Tony | director, officer: Chief Operating Officer | A-Award | Acquired | 26,510 | $0.00 |